Title (en)

GENETICALLY ENGINEERED IMMUNOGLOBULINS

Title (de)

GENTECHNISCH MANIPULIERTE IMMUNGLOBULINE

Title (fr)

IMMUNOGLOBULINES MANIPULEES GENETIQUEMENT

Publication

EP 0701573 A1 19960320 (EN)

Application

EP 94919299 A 19940525

Priority

• US 9406090 W 19940525
• US 6889593 A 19930528

Abstract (en)

[origin: WO9428026A1] This invention relates to the introduction of oligopeptide epitopes of influenza virus nucleoprotein for expressing within the three dimensional fold of an immunoglobulin (Ig) molecule, thus creating molecules useful to induce specific, biologically active anti-viral immunity.

IPC 1-7

C07K 15/28; C07H 15/00; C12N 15/00

IPC 8 full level

C12N 15/09 (2006.01); A61K 39/395 (2006.01); C07H 21/04 (2006.01); C07K 14/11 (2006.01); C07K 16/10 (2006.01); C07K 16/20 (2006.01); C07K 16/46 (2006.01); C12P 21/08 (2006.01); A61K 39/00 (2006.01); C12R 1/91 (2006.01)

CPC (source: EP US)

C07K 14/005 (2013.01 - EP); C07K 16/1018 (2013.01 - EP); C07K 16/205 (2013.01 - EP); A61K 39/00 (2013.01 - EP US); C12N 2760/16122 (2013.01 - EP)

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9428026 A1 19941208; CA 2163125 A1 19941208; EP 0701573 A1 19960320; JP H08510912 A 19961119

DOCDB simple family (application)

US 9406090 W 19940525; CA 2163125 A 19940525; EP 94919299 A 19940525; JP 50103295 A 19940525